Jennifer L. Taubert, EVP, WW Chair, Pharmaceuticals at JOHNSON & JOHNSON (JNJ), sold 153,846 shares at $176.78 ($27.2M) on 2022-11-22, disclosed to the SEC on 2022-11-23.
Open-market sale of $27.2M JNJ by EVP, WW Chair, Pharmaceuticals. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $176.78 | 76,923 | $13.6M | 50.0% |
| 2 | $176.78 | 76,923 | $13.6M | 50.0% |
| Total | $176.78 avg | 153,846 | $27.2M | 100% |
| Filing → |
| JNJ | SELL | 2024-02-12 | $18.6M | — | Filing → |